SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-094424
Filing Date
2021-03-25
Accepted
2021-03-25 16:04:38
Documents
79
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d41924d10k.htm   iXBRL 10-K 1534497
2 EX-4.2 d41924dex42.htm EX-4.2 15956
3 EX-10.7 d41924dex107.htm EX-10.7 112765
4 EX-10.8 d41924dex108.htm EX-10.8 56604
5 EX-10.18 d41924dex1018.htm EX-10.18 79699
6 EX-21.1 d41924dex211.htm EX-21.1 1989
7 EX-23.1 d41924dex231.htm EX-23.1 3257
8 EX-31.1 d41924dex311.htm EX-31.1 10403
9 EX-31.2 d41924dex312.htm EX-31.2 10413
10 EX-32.1 d41924dex321.htm EX-32.1 5052
16 GRAPHIC g41924dsp1.jpg GRAPHIC 7235
17 GRAPHIC g41924g73a92.jpg GRAPHIC 27946
  Complete submission text file 0001193125-21-094424.txt   7098036

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA cbay-20201231.xsd EX-101.SCH 42157
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20201231_cal.xml EX-101.CAL 42221
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20201231_def.xml EX-101.DEF 217547
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20201231_lab.xml EX-101.LAB 414367
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20201231_pre.xml EX-101.PRE 332891
18 EXTRACTED XBRL INSTANCE DOCUMENT d41924d10k_htm.xml XML 1126369
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36500 | Film No.: 21772314
SIC: 2834 Pharmaceutical Preparations